You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 15, April 18, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Informing Physicians About Promising New Treatments for Severe Illnesses

Robert Steinbrook, MD; Bernard Lo, MD

JAMA. 1990;263(15):2078-2082.


Abstract

Physicians are increasingly informed of promising new treatments for severe illnesses through unconventional communications such as press releases, press conferences, and direct mailings. These highly publicized announcements disseminate information quickly, often many months before new data are presented at medical meetings or published in peer-reviewed medical journals. Such unconventional communications, however, usually do not provide sufficient detail for physicians to evaluate new studies, answer patients' questions, or make recommendations. We suggest that physicians would be better informed about therapeutic advances through (1) expanded information in unconventional communications, (2) increased availability of information from the Food and Drug Administration, (3) early submission and accelerated review of key medical journal articles, and (4) expanded use of on-line computerized information sources. A commitment to inform physicians better about promising new treatments may help save or prolong the lives of patients with severe illnesses.

(JAMA. 1990;263:2078-2082)



Author Affiliations

From the Los Angeles Times, Los Angeles, Calif (Dr Steinbrook); and the Program in Medical Ethics, The Robert Wood Johnson Clinical Scholars Program, the Center for AIDS Prevention Studies, and the Division of General Internal Medicine, University of California at San Francisco (Dr Lo).


Footnotes

Reprint requests to Room A 405,400 Parnassus Ave, San Francisco, CA 94143-0320 (Dr Lo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Single-Drug Therapy for Hypertension in Men
Johnston et al.
NEJM 1993;329:1043-1045.
FULL TEXT  

Information Excess in Medicine: Overview, Relevance to Dermatology, and Strategies for Coping
Arndt
Arch Dermatol 1992;128:1249-1256.
ABSTRACT  

Change in Cholesterol Awareness and Action: Results From National Physician and Public Surveys
Schucker et al.
Arch Intern Med 1991;151:666-673.
ABSTRACT  

Informing Physicians About Promising New Treatments for Severe Disease
Hertzman
JAMA 1990;264:1947-1947.
ABSTRACT  

Informing Physicians About Promising New Treatments for Severe Disease
Cairns and Lowe
JAMA 1990;264:1947-1947.
ABSTRACT  

Informing Physicians About Promising New Treatments for Severe Disease
Harnes
JAMA 1990;264:1947-1948.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.